Cargando…

Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients

Detalles Bibliográficos
Autores principales:	Santaniello, Alessandro, Vigone, Barbara, Beretta, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832456/ https://www.ncbi.nlm.nih.gov/pubmed/32574572 http://dx.doi.org/10.1016/j.metabol.2020.154300

Ejemplares similares

Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19”
por: Solerte, Sebastiano Bruno, et al.
Publicado: (2020)

Abatacept to treat chronic intestinal pseudo-obstruction in five systemic sclerosis patients with a description of the index case
por: Vigone, Barbara, et al.
Publicado: (2018)

Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study
por: Vigone, Barbara, et al.
Publicado: (2017)

Letter to the editor
por: D’Alessandro, Vito, et al.
Publicado: (2012)

Letter to the Editor: Neurohospitalist and COVID-19
por: Duong, Lisa, et al.
Publicado: (2020)

Letter to the editor: The placenta and COVID-19
por: Al-Lami, Rasha A., et al.
Publicado: (2021)

Nearest neighbor imputation algorithms: a critical evaluation
por: Beretta, Lorenzo, et al.
Publicado: (2016)

Letter to the Editor Regarding “Letter to the Editor: Spinal and Neurosurgical Publications During the COVID-19 Era”
por: Akhaddar, Ali, et al.
Publicado: (2020)

Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
por: Giorgi, Mauro, et al.
Publicado: (2020)

COVID-19 and Phosphodiesterase Enzyme Type 5 Inhibitors
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2020)

Letter to the Editor: COVID-19 ‘Solutions’ in Bangladesh
por: Al-Zaman, Md. Sayeed
Publicado: (2021)

Letter to the editor: The effect of hydroxychloroquine on COVID-19
por: Demir, Canan, et al.
Publicado: (2022)

Phosphodiesterase 4 Inhibitors in Allergic Rhinitis/Rhinosinusitis
por: Janosova, Viera, et al.
Publicado: (2020)

Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
por: Li, Heng, et al.
Publicado: (2018)

Letter to Editor: Oral lesions in a patient with Covid-19
por: Soares, Ciro Dantas, et al.
Publicado: (2020)

Letter to the editor on the outcomes in fracture patients infected with COVID-19.
por: Rizkallah, Maroun, et al.
Publicado: (2020)

Letter to editor: the burden of covid-19 in neuro-oncological patients
por: Giorgia, Simonetti, et al.
Publicado: (2020)

Letter to the editor: Oral lesions in Covid 19 positive patients
por: Bin Dakhil, Alhanouf
Publicado: (2021)

Reply to the Letter to the Editor “Pathogenesis of pneumoperitoneum in COVID-19 patients”()
por: Gemio del Rey, Ignacio Antonio, et al.
Publicado: (2021)

Letter to the Editor [Letter]
por: Félix, Sylvie
Publicado: (2021)

Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
por: Zhou, Zeqi, et al.
Publicado: (2021)

Reply to the letter to the editor “Azithromycin, treatment in COVID-19”
por: Manafi, Navid, et al.
Publicado: (2021)

Letter to the Editor: Regarding COVID-19 in Children with Asthma
por: Özdemir, Öner
Publicado: (2021)

Letter to the Editor: Financial incentives for COVID-19 vaccination
por: Kim, Hyuncheol Bryant
Publicado: (2021)

Letter to Editor Regarding the OCEAN Study [Letter]
por: Yawn, Barbara P, et al.
Publicado: (2021)

Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19
por: Dalamaga, Maria, et al.
Publicado: (2020)

Letter to the Editor: The Role of D-Dimers in the Initial Evaluation of COVID-19 [Letter]
por: Patel, Sachin
Publicado: (2022)

Immunomodulation in COVID-19
por: Ingraham, Nicholas E, et al.
Publicado: (2020)

Letter to the Editor: Additional Recommendations before Intubation of COVID-19 Patients
por: Moghadam, Vahid Damanpak, et al.
Publicado: (2020)

Letter to the Editor Management of Neurosurgical Patients During the COVID-19 Pandemic
por: Spina, Alfio, et al.
Publicado: (2020)

Insomnia drug therapy in COVID-19 patients; a letter to editor
por: Rismanbaf, Ali
Publicado: (2020)

Letter to the Editor: Characteristics of Liver Transplant Patients Admitted with COVID-19
por: Mansoor, Emad, et al.
Publicado: (2021)

Phosphodiesterase (PDE)-4 Inhibitors and COPD Correlation with Cancer
por: Organtzis, John, et al.
Publicado: (2014)

Selective Phosphodiesterase 4B Inhibitors: A Review
por: Azam, Mohammed Afzal, et al.
Publicado: (2014)

Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases
por: Kawamatawong, Theerasuk
Publicado: (2021)

Letter to the Editor
por: Sezer, Taylan Özgür, et al.
Publicado: (2020)

Letter to the Editor
por: De Simone, Michele, et al.
Publicado: (2020)

Letter to the Editor
por: Hassing, Gerardus J., et al.
Publicado: (2020)

Letter to the Editor
por: Mudd, Shawna S., et al.
Publicado: (2020)

Letter to editor
por: Magli, M. Cristina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_77bug8e74c6u8opgf90eea8f70